The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.

Cookies

This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy
Accept
01 February 2024

In 2023, Darnytsia Provided Hospitals with Medicines Worth about UAH 49 Million on a Charitable Basis

01 February 2024

During 2023, the Pharmaceutical Company ‘Darnytsia’ provided hospitals with medicines worth about UAH 49 million on a charitable basis.

The lion’s share of Darnytsia medicines was sent to hospitals, medical units, military hospitals, and other medical institutions that treat defenders of our country, men and women, every day.

Civilians, children, the elderly, and socially vulnerable groups of the population affected by enemy strikes also receive medicinal products from Darnytsia.

With the help of charitable organizations and volunteers, medicines from Darnytsia are distributed throughout Ukraine, including the eastern and southern regions, where the security situation is critical, and hospitals often face the shortage of medicines that are difficult to deliver to these regions.

Charitable assistance with medicinal products makes medical care more accessible and improves the quality of life of patients. Providing charitable assistance in the form of medicines from Darnytsia at all stages complies with safety and ethical standards.

‘Charity is an integral part of the corporate culture of Darnytsia.  As the leader of the national pharmaceutical market, Darnytsia constantly helps not only with funds, but also with medicines. This is the least we can do for our male and female defenders and civilian Ukrainians who suffer daily from the barbaric attacks of the enemy.

We will continue to help in 2024. In general, we will do this as long as it takes’, Vasyl Hubarets, Corporate Communications Director at Pharmaceutical Company ‘Darnytsia’, says.

Share:
Specialized edition for medical institutions and doctors.